1 Rose M,McMahon FG.Some problems with anti-hypertensive drug studies in the context of the new guide line.Am J Hyper tens,1990;3:151
2 Giuseppe M,Daniele A,Gerard J,et al.Effect of the converting enzyme inhibition benazepril on the progression of chronic renal insufficiency.N Engl J Med,1996;334:939
3 Hollenberg NK,Adams DF.The renal circulation in hypertensive disease.Am J Med,1976;60:7 73
4 Valve E,Gammaro L,Bedogna V,et al,Systemic and renal haemodynamic changes of two-months treatment with enalapril in patient swithessential hypertension.Int J Clin Pharmacol The rap,1987;25:656
5 Richer C,Doussau MP,Giudicelli JF.Systemic and regional hemodynamic pro file of five angiotensin-converting enzyme inhibitions in the spontaneously hypertensive rat.Am J Cardiol,1987;59:1 2D
6 Heeg JE,De Jong PE,Van der Hem GK,et al.Reduction of proteinura by angiotensin-converting enzyme inhibition.Kidey Int,1987;32:7 8
7 Dwokin L,Feinet HD,Randazzo J,Glomerular hyper tension and injury in the deoxycortcosterone-salt rats on antighpertensive therapy.Kidney Int,1987;31:718
8 Bohrer M P,Deen WM,Robertson CR,et al.Mechanism of angiotensin Ⅱ-proteinuria in the rat.Am J Phy siol1977;233:F13
9 Friedrich SP,Lorell BM,Rousseau M F,et al.In-tracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.Circulation,1994;90(6):2761
10 Haber HL,Powers ER,Gimpile LW,et al.Intra-coronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hyper-tension left ventricular hypertrophy.Circulaton,1994;89(6):2616
11 Guller B,Reeves R,IL,Desilva J.Haemodynamics during long-term use of benazepril alone or with concomitant hydrochlorothiazide.J Clin Pharma.1989;29(9):847
12 Koylan N,Oncrul A,Mercanoglu F,et al.The short-term efforts of cilazapril on left ventricular diastolic function.J Cardiovasc Pharmacol,1994;24(suppl 3):S42
13 Gosse P,Grellet J,Bonoron S,et al.Effects of perindopril on left ventricular hypertrophy coronary blood flow,and mechanical properties of Cardiac muscle in renovascular hypertensive rats.Am J Hy-per tens.1991;4:S235
14 Bastrukov A,Effect of capton on left ventricula rdi-astolic function in patients coronary heart disease concurrent with permament a riterial hypertension.Kardiologiya,1993;33(4):30
15 Colfen HT,Ribner HS,Gradman A.Effects of once daily benazepril therapy one xercise tolerance and manifestations of chroic congestve heart failure.Am J Cardiol,1992;70:3 54
16 Vidt DG.A controlled Multiclinic Study to compare the antihypertensive effects of M K-421,hydro chloro thiazide,and M K-421 combined with hydrochlorothiazide in patients with mild to moderate essential hy-pertension.J Hypertens,1984;2(suppl 2):81
17 Hansson L,Zanchetti A,The Hype rtension Optimal Trea tment (HOT)Study-patient characteristics,risk profiles,and early blood pressure results.Blood Pressure,1994;3:222
18 Hill JF,Bulpitt CJ,Fletcher AE.Angiotensin con-verting enzyme inhibitors and quality of life:The Europe an Tria l.J Hypertens,1985;3(suppl 2):S 91
19 Pool JL,Gennari J,Goldstein R,et al.Controlled multicenter study of the antihypertensive effects of lisinopril,hydrochlorothiazide,lisinopril plus hy-drochloro thiazide in the treatment of 394 patients with mild to moder ate essential hypertension.J Cardiovasc Pharmacol,1987;9(suppl 3):S 36
20 陈晓亮,黄元伟.苯那普利和硝苯地平治疗轻中度高血压病观察,浙江医学,1998;20(3):147
21 The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure.Lancet,1993;342:821
22 Hall AS,Mur ray GD,Ball SG,on behalf of the AIREX study Investigators.Follow-up study of patientsr andomlyallocated ramipril or placebo for heart failure after acute myocardial infarction:AIRE Ex-tension (AIREX)Study,Lancet,1997;349:1493
23 Ludwig M,Stumpe KO,Heagerty AM,et al.Vas-cular wall thickness in hypertension:the perindopril regression of vascular thickening European communi-tytril (PRO TECT).J Hypertens,1993;11(suppls):s316
24 Lievre M,Gueret P,Delair S,et al.ACE-inhibitorr eduction in left ventricular mass independent of changes in blood pressure in hypertensive patients with left ventricular hyper trophy.Hyper tension,1993;22:49
25 刘国仗,陈孟勤,周北凡,等.我国高血压研究的主要成就.中华心血管病杂志,1999;2 7(4):248
26 全国高血压抽样调查协作组.中国高血压的患病率、知晓率及治疗和控制状况:1991 年抽样调查结果.中国高血压杂志,1995;3(增刊):14
27 全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势.中国高血压杂志,1995;3(增刊):7
28 Kannei WB.Pre valence incidence and hazards of hy-per tension in the olderly.Geriatr Cardiovasc Med 1998;1:5

[1]	CHEN Xi, LI Yongjun. Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
[2]	XU Jianfei, LIN Li. Research progress in pharmacological and non-pharmacological treatments of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
[3]	YUAN Zhen, CHEN Bilian. Review of bleeding events in clinical studies of clopidogrel [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349.
[4]	XING Kai, GONG Jinyu, LUO Jianquan. Advances on pharmacogenomics of diuretics-related adverse reactions [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212.
[5]	DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
[6]	PU Chun, TAO Qingsong, ZHU Xiang, QIN Mingming, WU Qiwen, FENG Gang. Value of three cardiac markers in the early diagnosis of acute myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 82-86.
[7]	JIANG Peng-li, WU Jing, SUN He. Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1132-1138.
[8]	WANG Pan, XIE Shan-shan, GUO Jian-jun, BU Hai-zhi, CHEN Xi-jing. Research overview in absorption, distribution, metabolism and excretion of dihydropyridine calcium antagonists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 937-943.
[9]	WANG Zhen-shan, LI Ling, DENG Xiao-lan, LI Hui, YU Min, YAN Jin, CHEN Ben-mei, YANG Guo-ping, OU-YANG Dong-sheng. LC-MS determination of terazosin in human plasma and application [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 530-534.
[10]	ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang. Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165.
[11]	WANG Zhan-qing, WANG Jin-ping, XU Jing-feng. Isosorbide dinitrate induces late preconditioning against myocardial infarction in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1385-1388.
[12]	ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua. Research progress of xanthine oxidoreductase in biological functions and its inhibitor development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086.
[13]	XUE Hao, GAO Min, LIU Guo-shu, WANG Hai. Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128.
[14]	WANG Zhan-qing, YING Xiang-yu, XU Jing-feng. Advances in preclinical studies on combination therapy of myocardial ischemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 847-850.
[15]	YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan. Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments